Karlin Dan's Form 4 filing
Definium Therapeutics, Inc. (DFTX) · filed Sep 27, 2022
- Accession no.
- 0000899243-22-032169
- Filed
- Sep 27, 2022
- Trade date
- Sep 26-27, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $6.87K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Karlin DanCIK 0001897618 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The Common Shares were sold in one transaction at a price of $7.60 CAD Dollars. This represents the price in United States Dollars using the conversion rate on September 26, 2022.
Referenced by the price of 1 transaction in Table I.
- F4
The Common Shares were sold in one transaction at a price of $8.06 CAD Dollars. This represents the price in United States Dollars using the conversion rate on September 27, 2022.
Referenced by the price of 1 transaction in Table I.